[go: up one dir, main page]

PL2755963T3 - Nowe pochodne dihydrochinolin-2-onu - Google Patents

Nowe pochodne dihydrochinolin-2-onu

Info

Publication number
PL2755963T3
PL2755963T3 PL12756741T PL12756741T PL2755963T3 PL 2755963 T3 PL2755963 T3 PL 2755963T3 PL 12756741 T PL12756741 T PL 12756741T PL 12756741 T PL12756741 T PL 12756741T PL 2755963 T3 PL2755963 T3 PL 2755963T3
Authority
PL
Poland
Prior art keywords
derivatives
dihydroquinoline
new
new dihydroquinoline
Prior art date
Application number
PL12756741T
Other languages
English (en)
Inventor
Johannes Aebi
Kurt Amrein
Benoit Hornsperger
Henner Knust
Bernd Kuhn
Yongfu Liu
Hans P. Maerki
Alexander V. Mayweg
Peter Mohr
Xuefei Tan
Mingwei Zhou
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL2755963T3 publication Critical patent/PL2755963T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL12756741T 2011-09-15 2012-09-12 Nowe pochodne dihydrochinolin-2-onu PL2755963T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2011079673 2011-09-15
EP12756741.0A EP2755963B1 (en) 2011-09-15 2012-09-12 New dihydroquinoline-2-one derivatives
PCT/EP2012/067744 WO2013037779A1 (en) 2011-09-15 2012-09-12 New dihydroquinoline-2-one derivatives

Publications (1)

Publication Number Publication Date
PL2755963T3 true PL2755963T3 (pl) 2020-07-27

Family

ID=46829775

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12756741T PL2755963T3 (pl) 2011-09-15 2012-09-12 Nowe pochodne dihydrochinolin-2-onu

Country Status (33)

Country Link
US (1) US9260408B2 (pl)
EP (2) EP3653618B1 (pl)
JP (1) JP6012735B2 (pl)
KR (1) KR101785143B1 (pl)
CN (1) CN103814021B (pl)
AR (1) AR087901A1 (pl)
AU (1) AU2012307509B2 (pl)
BR (1) BR112014006283B1 (pl)
CA (1) CA2846785C (pl)
CL (1) CL2014000604A1 (pl)
CO (1) CO6890099A2 (pl)
CR (1) CR20140091A (pl)
DK (1) DK2755963T3 (pl)
EA (1) EA035757B1 (pl)
EC (1) ECSP14013245A (pl)
ES (2) ES2763332T3 (pl)
HR (1) HRP20192323T1 (pl)
HU (1) HUE047771T2 (pl)
IL (1) IL231229A0 (pl)
LT (1) LT2755963T (pl)
MX (1) MX358376B (pl)
MY (1) MY169043A (pl)
PE (1) PE20141372A1 (pl)
PH (1) PH12014500434A1 (pl)
PL (1) PL2755963T3 (pl)
PT (1) PT2755963T (pl)
RS (1) RS59737B1 (pl)
SG (1) SG11201400679WA (pl)
SI (1) SI2755963T1 (pl)
TW (1) TWI462914B (pl)
UA (1) UA111626C2 (pl)
WO (1) WO2013037779A1 (pl)
ZA (1) ZA201401884B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2964628B1 (en) * 2013-03-08 2019-09-11 F.Hoffmann-La Roche Ag New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp11b2 or cyp11b1) inhibitors
CN105073732B (zh) * 2013-03-14 2017-07-21 豪夫迈·罗氏有限公司 用作醛固酮合酶抑制剂的二氢喹啉‑2‑酮衍生物
BR112015023280A2 (pt) 2013-03-14 2017-07-18 Hoffmann La Roche derivados de dihidroquinolin-2-ona para utilização como inibidores da aldosterona sintase
US9682983B2 (en) 2013-03-14 2017-06-20 The Brigham And Women's Hospital, Inc. BMP inhibitors and methods of use thereof
JP6067181B2 (ja) * 2013-04-30 2017-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アルドステロンシンターゼ阻害薬
WO2014191340A1 (en) 2013-05-27 2014-12-04 F. Hoffmann-La Roche Ag New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
ES2763338T3 (es) * 2013-05-27 2020-05-28 Hoffmann La Roche Nuevos compuestos de 3,4-dihidro-2H-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona
CN105143205B (zh) * 2013-05-27 2018-02-02 豪夫迈·罗氏有限公司 新的3,4‑二氢‑2h‑异喹啉‑1‑酮和2,3‑二氢‑异吲哚‑1‑酮化合物
CN105308045B (zh) * 2013-05-27 2017-05-17 豪夫迈·罗氏有限公司 新的3,4‑二氢‑2h‑异喹啉‑1‑酮和2,3‑二氢‑异吲哚‑1‑酮化合物
WO2015125858A1 (ja) * 2014-02-24 2015-08-27 日本曹達株式会社 ヘテロアリール化合物およびその用途
JP2017514793A (ja) * 2014-03-26 2017-06-08 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. Bmp阻害用組成物及びbmp阻害方法
MY176401A (en) 2014-04-24 2020-08-05 Mitsubishi Tanabe Pharma Corp Novel disubstituted 1,2,4-triazine compound
US10513521B2 (en) 2014-07-15 2019-12-24 The Brigham And Women's Hospital, Inc. Compositions and methods for inhibiting BMP
KR102550852B1 (ko) * 2014-10-08 2023-07-05 에프. 호프만-라 로슈 아게 알도스테론 신타아제 억제제로서의 스피로다이아민 유도체
JP6669734B2 (ja) 2014-10-31 2020-03-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ピラゾリル−3,4−ジドヒドロキノリン−2−オン・アルドステロン合成酵素阻害剤
WO2016066662A1 (en) * 2014-10-31 2016-05-06 F. Hoffmann-La Roche Ag New dihydroquinoline pyrazolyl compounds as aldosterone synthase inhibitors
EP3212630B1 (en) * 2014-10-31 2022-05-18 F. Hoffmann-La Roche AG New dihydroquinoline pyrazolyl compounds
CN108368083B (zh) 2015-08-31 2022-02-01 东亚首希控股股份有限公司 杂芳基化合物及其作为治疗性药物的用途
JP6314196B2 (ja) * 2015-10-22 2018-04-18 田辺三菱製薬株式会社 医薬組成物
JP6545275B2 (ja) * 2015-10-23 2019-07-17 田辺三菱製薬株式会社 新規含窒素芳香族複素環化合物
WO2018071343A1 (en) * 2016-10-10 2018-04-19 Dong-A Socio Holdings Co., Ltd. Heteroaryl compounds and their use as mer inhibitors
MA48594B1 (fr) * 2016-12-08 2022-05-31 Hoffmann La Roche Nouveaux dérivés d'éther d'isoxazolyle en tant que pam alpha5 gaba a
CN113767095A (zh) 2019-05-01 2021-12-07 勃林格殷格翰国际有限公司 (r)-4-溴苯磺酸(2-甲基环氧乙烷-2-基)甲酯
WO2023063851A1 (en) * 2021-10-13 2023-04-20 «Target Medicals» Limited Liability Company Inhibitors of human aldosterone synthase (cyp11b2)
TW202339719A (zh) 2021-12-14 2023-10-16 德商百靈佳殷格翰國際股份有限公司 用於治療慢性腎臟病之醛固酮合成酶抑制劑
AU2023378302A1 (en) * 2022-11-10 2025-04-10 «Target Medicals» Limited Liability Company Inhibitors of human aldosterone synthase (cyp11b2)
CN120187713A (zh) * 2022-11-23 2025-06-20 上海翰森生物医药科技有限公司 吡啶多环类化合物抑制剂、及其制备方法和应用
WO2024235165A1 (zh) * 2023-05-12 2024-11-21 南京明德新药研发有限公司 含氮杂环类化合物及其应用
TW202535378A (zh) * 2023-12-22 2025-09-16 大陸商上海翊石醫藥科技有限公司 一種芳雜環化合物及其製備方法和應用
CN120289471B (zh) * 2024-03-01 2025-10-17 浙江扬厉医药技术有限公司 吡喃并吡啶类化合物、其制备方法、药物组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334282D0 (en) * 1983-12-22 1984-02-01 Pfizer Ltd Quinolone inotropic agents
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
CN85100796A (zh) * 1985-04-01 1986-10-01 辉瑞公司 喹啉酮衍生物的制备方法
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
EP1874753A2 (en) 2005-04-14 2008-01-09 Smithkline Beecham Corporation Compounds, compositions and methods
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
AU2010247391A1 (en) 2009-05-15 2011-12-01 Novartis Ag Benzoxazolone derivatives as aldosterone synthase inhibitors
SG175925A1 (en) 2009-05-15 2011-12-29 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2

Also Published As

Publication number Publication date
PH12014500434A1 (en) 2017-04-19
MX358376B (es) 2018-08-16
AU2012307509B2 (en) 2017-06-29
LT2755963T (lt) 2020-01-27
SG11201400679WA (en) 2014-04-28
CA2846785C (en) 2020-09-22
EP3653618A1 (en) 2020-05-20
IL231229A0 (en) 2014-04-30
CO6890099A2 (es) 2014-03-10
EA035757B1 (ru) 2020-08-05
CR20140091A (es) 2014-06-03
BR112014006283B1 (pt) 2021-11-03
PT2755963T (pt) 2020-01-10
CA2846785A1 (en) 2013-03-21
KR20140067121A (ko) 2014-06-03
US20130072679A1 (en) 2013-03-21
TWI462914B (zh) 2014-12-01
CL2014000604A1 (es) 2014-10-17
MX2014002770A (es) 2014-06-05
CN103814021B (zh) 2016-12-21
UA111626C2 (uk) 2016-05-25
EP3653618B1 (en) 2025-01-08
ES3016782T3 (en) 2025-05-09
CN103814021A (zh) 2014-05-21
AU2012307509A1 (en) 2014-03-13
EA201490596A1 (ru) 2014-07-30
ECSP14013245A (es) 2014-07-31
EP2755963A1 (en) 2014-07-23
BR112014006283A2 (pt) 2017-04-11
KR101785143B1 (ko) 2017-10-12
TW201315724A (zh) 2013-04-16
HUE047771T2 (hu) 2020-05-28
JP2014527077A (ja) 2014-10-09
HRP20192323T1 (hr) 2020-03-20
ES2763332T3 (es) 2020-05-28
AR087901A1 (es) 2014-04-23
WO2013037779A1 (en) 2013-03-21
RS59737B1 (sr) 2020-02-28
US9260408B2 (en) 2016-02-16
SI2755963T1 (sl) 2020-01-31
MY169043A (en) 2019-02-07
DK2755963T3 (da) 2020-01-13
JP6012735B2 (ja) 2016-10-25
PE20141372A1 (es) 2014-10-13
EP2755963B1 (en) 2019-10-30
NZ621599A (en) 2016-07-29
ZA201401884B (en) 2019-11-27

Similar Documents

Publication Publication Date Title
ZA201401884B (en) New dihydroquinoline-2-one derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
SG11201401937YA (en) New aryl-quinoline derivatives
IL247640A0 (en) History of heteroaryl piperidine
AP2014007621A0 (en) 2-Thiopyrimidinones
PL2838883T3 (pl) Nowe pochodne fenylo-tetrahydroizochinoliny
EP2687531A4 (en) TETRAHYDROCARBOLINE DERIVATIVE
PL2793866T5 (pl) Tabletka dwuwarstwowa zawierająca chlorowodorek benazeprylu i pimobendan
EP2740730A4 (en) DIBENZOOXEPINE DERIVATIVE
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
AU5026P (en) Goldstrike Agapanthus inapertus
AU4540P (en) BUNNAN Baloskion tetraphyllum
ZA201403872B (en) New combination
GB201109229D0 (en) New uses
GB201115238D0 (en) Pit-stop easy
AP00723S1 (en) Autorickshaw
AP2011000390S (en) Kuppkraft
AU338110S (en) Barstool
AU2011035V (en) DBK02 Babingtonia virgata
AU338420S (en) Kettlebell
GB201119520D0 (en) Compact-a-can
AU339857S (en) Orchidometer